I agree that this site is using cookies. You can find further informations here.
X
Berger, Fréderique
191  results:
OpenAccess-fulltext X
Search for persons X
?
1

Randomised, open-label, multicentric phase III trial to eva..:

Berger, Frédérique ; Marce, Margaux ; Delaloge, Suzette...
info:eu-repo/semantics/altIdentifier/doi/10.1136/bmjopen-2021-055821.  , 2022
Link: https://hal.science/hal-..
 
?
2

Randomised, open-label, multicentric phase III trial to eva..:

Berger, Frédérique ; Marce, Margaux ; Delaloge, Suzette...
info:eu-repo/semantics/altIdentifier/doi/10.1136/bmjopen-2021-055821.  , 2022
Link: https://hal.science/hal-..
 
?
3

Author Correction: Cytidine deaminase activity increases in..:

Buhagiar‑Labarchède, Géraldine ; Onclercq‑Delic, Rosine ; Vacher, Sophie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722649/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Concurrent Olaparib and Radiotherapy in Patients With Tripl..:

Loap, Pierre ; Loirat, Delphine ; Berger, Frederique...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614672/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

Randomised, open-label, multicentric phase III trial to eva..:

Berger, Frédérique ; Marce, Margaux ; Delaloge, Suzette...
info:eu-repo/semantics/altIdentifier/doi/10.1136/bmjopen-2021-055821.  , 2022
Link: https://hal.science/hal-..
 
?
6

Randomised, open-label, multicentric phase III trial to eva..:

Berger, Frédérique ; Marce, Margaux ; Delaloge, Suzette...
info:eu-repo/semantics/altIdentifier/doi/10.1136/bmjopen-2021-055821.  , 2022
Link: https://hal.science/hal-..
 
?
7

Randomised, open-label, multicentric phase III trial to eva..:

Berger, Frédérique ; Marce, Margaux ; Delaloge, Suzette...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896060/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Multimodal liquid biopsy for early monitoring and outcome p..:

Bortolini Silveira, Amanda ; Bidard, François-Clément ; Tanguy, Marie-Laure...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41523-021-00319-4.  , 2021
Link: https://hal.science/hal-..
 
?
9

Multimodal liquid biopsy for early monitoring and outcome p..:

Bortolini Silveira, Amanda ; Bidard, François-Clément ; Tanguy, Marie-Laure...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41523-021-00319-4.  , 2021
Link: https://hal.science/hal-..
 
?
10

Multimodal liquid biopsy for early monitoring and outcome p..:

Bortolini Silveira, Amanda ; Bidard, François-Clément ; Tanguy, Marie-Laure...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41523-021-00319-4.  , 2021
Link: https://hal.science/hal-..
 
?
11

Clinical utility of circulating tumour cell-based monitorin..:

Cabel, Luc ; Berger, Frédérique ; Cottu, Paul...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007590/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Multimodal liquid biopsy for early monitoring and outcome p..:

Bortolini Silveira, Amanda ; Bidard, François-Clément ; Tanguy, Marie-Laure...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41523-021-00319-4.  , 2021
Link: https://hal.science/hal-..
 
?
13

CENP-A Subnuclear Localization Pattern as Marker Predicting..:

Verrelle, Pierre ; Meseure, Didier ; Berger, Frédérique...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13163928.  , 2021
Link: https://hal.sorbonne-uni..
 
?
14

CENP-A Subnuclear Localization Pattern as Marker Predicting..:

Verrelle, Pierre ; Meseure, Didier ; Berger, Frédérique...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13163928.  , 2021
Link: https://hal.sorbonne-uni..
 
?
15

Multimodal liquid biopsy for early monitoring and outcome p..:

Bortolini Silveira, Amanda ; Bidard, François-Clément ; Tanguy, Marie-Laure...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41523-021-00319-4.  , 2021
Link: https://hal.science/hal-..
 
1-15